DK0473671T3 - Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel - Google Patents

Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel

Info

Publication number
DK0473671T3
DK0473671T3 DK90908385.9T DK90908385T DK0473671T3 DK 0473671 T3 DK0473671 T3 DK 0473671T3 DK 90908385 T DK90908385 T DK 90908385T DK 0473671 T3 DK0473671 T3 DK 0473671T3
Authority
DK
Denmark
Prior art keywords
prepare
sigma receptor
receptor ligands
anxiolytic agent
anxiolytic
Prior art date
Application number
DK90908385.9T
Other languages
Danish (da)
English (en)
Inventor
Eckard Weber
John F W Keana
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Application granted granted Critical
Publication of DK0473671T3 publication Critical patent/DK0473671T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK90908385.9T 1989-05-02 1990-05-02 Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel DK0473671T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34649489A 1989-05-02 1989-05-02

Publications (1)

Publication Number Publication Date
DK0473671T3 true DK0473671T3 (da) 1994-09-19

Family

ID=23359655

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908385.9T DK0473671T3 (da) 1989-05-02 1990-05-02 Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel

Country Status (9)

Country Link
EP (1) EP0473671B1 (de)
JP (1) JPH05500798A (de)
AT (1) ATE110265T1 (de)
AU (1) AU642881B2 (de)
CA (1) CA2054211A1 (de)
DE (1) DE69011859T2 (de)
DK (1) DK0473671T3 (de)
ES (1) ES2057568T3 (de)
WO (1) WO1990014067A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5502255A (en) * 1986-07-10 1996-03-26 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Substituted guanidines having high binding to the sigma receptor and the use thereof
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
DK0517852T3 (da) 1990-03-02 2002-10-07 Oregon State Tri- og tetrasubstituerede guanidinerog disses anvendelse som excitatoriske aminosyre-antagonister
EP0532642A1 (de) * 1990-05-25 1993-03-24 STATE OF OREGON, acting through OREGON STATE BOARD OF HIGHER EDUCATION, acting for OREGON HEALTH SC. UNIV. AND UNIV. OF OREGON Substituierte guanidine, welche eine hohe sigma-rezeptor-bindungsaffinität besitzen, und ihre verwendung
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5403861A (en) * 1991-02-08 1995-04-04 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
KR20030097618A (ko) * 1993-05-27 2003-12-31 캠브리지 뉴로사이언스, 인코포레이티드 치료용 치환 구아니딘류
EP0746316A4 (de) * 1993-11-22 1997-12-10 Cambridge Neuroscience Inc Guanidine zur therapeutischen anwendung
WO1995014461A1 (en) * 1993-11-23 1995-06-01 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
CA2182302A1 (en) 1994-02-03 1995-08-10 Stanley M. Goldin Therapeutic guanidines
WO1995023132A1 (en) * 1994-02-23 1995-08-31 Cambridge Neuroscience, Inc. Blockers of ion channels and methods of use thereof
US6875759B1 (en) 1999-07-21 2005-04-05 Kadmus Pharmaceuticals Substituted guanidines and the use thereof
EP1749824A1 (de) 2005-08-03 2007-02-07 Neuro3D Benzodiazepinederivate, Herstellung und Verwendung als Arzneimittel
WO2007022964A2 (de) 2005-08-24 2007-03-01 Abbott Gmbh & Co. Kg Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
EP2377530A3 (de) 2005-10-21 2012-06-20 Braincells, Inc. Modulation von Neurogenese durch PDE-Hemmung
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP6397407B2 (ja) * 2012-07-19 2018-09-26 ドレクセル ユニバーシティ 細胞タンパク質ホメオスタシスを調節するためのシグマ受容体リガンド
US11117870B2 (en) 2017-11-01 2021-09-14 Drexel University Compounds, compositions, and methods for treating diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709094A (en) * 1986-07-10 1987-11-24 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Sigma brain receptor ligands and their use

Also Published As

Publication number Publication date
DE69011859D1 (de) 1994-09-29
DE69011859T2 (de) 1994-12-15
ATE110265T1 (de) 1994-09-15
ES2057568T3 (es) 1994-10-16
CA2054211A1 (en) 1990-11-03
EP0473671A1 (de) 1992-03-11
AU642881B2 (en) 1993-11-04
EP0473671B1 (de) 1994-08-24
AU5728790A (en) 1990-12-18
WO1990014067A2 (en) 1990-11-29
JPH05500798A (ja) 1993-02-18
WO1990014067A3 (en) 1991-04-04
EP0473671A4 (en) 1992-04-01

Similar Documents

Publication Publication Date Title
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
MX9101637A (es) Herbicidas de aril-halogenoalquilpirazoles substituidos
BR0012243A (pt) Triflúor butenos nematocidas
NO952494L (no) Nytt protein fra urin med betegnelse komponent B
ES521422A0 (es) Procedimiento para la obtencion de derivados de carboxilamida n-glicosilados.
DK0415613T3 (da) Anvendelse af sertralin til behandling af præmatur ejakulation
ES2059121T5 (es) Uso de agentes sensibilizantes de la insulina para tratar la hipertension.
LV10449A (lv) Jauni hromana un tiohromana atvasinajumi
DK261490D0 (da) New pharmaceutical compound
FI972703A (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
DK455088D0 (da) Syntetiske receptoranaloger
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
SE8700156D0 (sv) Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav
DE59207900D1 (de) Iloprost mit wirkung gegen cerebrale malaria
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
DE3669159D1 (de) Triazinderivate, verfahren zur herstellung dieser derivate und herbizide, welche diese derivate als wirksame komponente enthalten.
ES2051953T3 (es) Derivados isomeros de trimetilbiciclo(4,3,0)nonano.
DK134982A (da) Fremgangsmaade til fremstilling af guanidinopyrimidiner
SE9501773D0 (sv) New use
ES1013934Y (es) Pata perfeccionada para mesas de billar.
ES1014611Y (es) Pata perfeccionada para mesas.
ES2025787T3 (es) Procedimiento de tratamiento de madera.
MX9202927A (es) [7-(3-amino disubstituidas)fenil]pirazolo[1,5-a]pirimidinas composicion farmaceutica que las contiene.